BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23379929)

  • 1. Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy.
    Buse S; Höfner T; Müller SC; Hermann E; Wieland WF; May M; Stief CG; Bastian PJ; Hohenfellner M; Haferkamp A
    Int J Urol; 2013 Sep; 20(9):866-71. PubMed ID: 23379929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic impact of incidental prostate cancer following radical cystoprostatectomy: a nationwide analysis.
    Jønck S; Helgstrand JT; Røder MA; Klemann N; Grønkaer Toft B; Brasso K
    Scand J Urol; 2018; 52(5-6):358-363. PubMed ID: 30624125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment to characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy.
    Szarvas T
    Int J Urol; 2013 Sep; 20(9):872. PubMed ID: 23379970
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidental prostate cancer in Asian men: high prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy.
    Yang X; Monn MF; Liu L; Liu Y; Su J; Lyu T; Gong Y; Wang L; Davidson DD; Cheng L
    Prostate; 2015 Jun; 75(8):845-54. PubMed ID: 25704311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder.
    Pritchett TR; Moreno J; Warner NE; Lieskovsky G; Nichols PW; Cook BA; Skinner DG
    J Urol; 1988 Jun; 139(6):1214-6. PubMed ID: 3373591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
    Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
    J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should prostate cancer status be determined in patients undergoing radical cystoprostatectomy?
    Sanli O; Acar O; Celtik M; Oktar T; Kilicaraslan I; Ozcan F; Tunc M; Esen T
    Urol Int; 2006; 77(4):307-10. PubMed ID: 17135779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.
    Thomas C; Wiesner C; Melchior S; Gillitzer R; Schmidt F; Thüroff JW
    J Urol; 2008 Nov; 180(5):1938-41; discussion 1941. PubMed ID: 18801501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy.
    Wu S; Lin SX; Lu M; Subtelny AO; Wang Z; Dahl DM; Olumi AF; Wu CL
    Int Urol Nephrol; 2019 Sep; 51(9):1527-1535. PubMed ID: 31183659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental prostate cancer in patients undergoing radical cystoprostatectomy for bladder cancer.
    Hiros M; Spahović H; Selimović M; Sadović S
    Bosn J Basic Med Sci; 2008 May; 8(2):147-51. PubMed ID: 18498265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer identified incidentally in the prostate following radical cystoprostatectomy: an Australian study.
    Ahmadi N; Delprado WJ; Brooks AJ; Brenner PC; Coombes GM; Grant A; Patel MI
    ANZ J Surg; 2014 Jun; 84(6):473-6. PubMed ID: 23216652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
    Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
    Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-Analysis of 13,140 Patients.
    Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Stenzl A; Gakis G
    J Urol; 2017 Feb; 197(2):385-390. PubMed ID: 27569436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy.
    Reese JH; Freiha FS; Gelb AB; Lum BL; Torti FM
    J Urol; 1992 Jan; 147(1):92-5. PubMed ID: 1729557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer.
    Abbas F; Hochberg D; Civantos F; Soloway M
    Eur Urol; 1996; 30(3):322-6. PubMed ID: 8931964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy.
    Gregorakis AK; Stefanakis S; Malovrouvas D; Petraki K; Gourgiotis D; Scorilas A
    Prostate; 2008 May; 68(7):759-65. PubMed ID: 18213630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Cancer among Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer in the Department of Urology in a Tertiary Care Centre.
    Mishra P; Jiongming L; Jianhe L; Kewei F; Yongming J; Wang G; Pei L; Tongxing Y
    JNMA J Nepal Med Assoc; 2023 Oct; 61(266):782-786. PubMed ID: 38289768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy.
    Weizer AZ; Shah RB; Lee CT; Gilbert SM; Daignault S; Montie JE; Wood DP
    Urol Oncol; 2007; 25(6):460-4. PubMed ID: 18047952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of patients with concurrent primary tumors of bladder and prostate.
    Selli C; Hinshaw W; Wolfe JA; Paulson DF
    Urology; 1983 Jun; 21(6):562-5. PubMed ID: 6868226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous primary carcinomas of the bladder and prostate.
    Lee SH; Chang PL; Chen SM; Sun GH; Chen CL; Shen BY; Wu YS; Tsui KH
    Asian J Androl; 2006 May; 8(3):357-9. PubMed ID: 16625287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.